Gastroesophageal Reflux Disease Relief in Patients Treated with Rabeprazole 20 mg versus Omeprazole 20 mg: A Meta-Analysis

Background. Randomized controlled trials (RCTs) have been conducted comparing the efficacy of rabeprazole 20 mg or omeprazole 20 mg once daily for patients with erosive gastroesophageal reflux disease (GERD). Until now, no study has synthesized all available data examining this issue. Method. Medlin...

Descripción completa

Detalles Bibliográficos
Autores principales: Xia, X. M., Wang, H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782839/
https://www.ncbi.nlm.nih.gov/pubmed/24106498
http://dx.doi.org/10.1155/2013/327571

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3782839/
https://www.ncbi.nlm.nih.gov/pubmed/24106498
http://dx.doi.org/10.1155/2013/327571

Ejemplares similares